Atherosclerosis
Volume 148, Issue 1 , Pages 95-100 , January 2000

Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? A nested case control study from the West of Scotland Coronary Prevention Study

  • Allan Gaw

      Affiliations

    • Department of Pathological Biochemistry, 4th Floor Queen Elizabeth Building, Royal Infirmary University/NHS Trust, Glasgow G31 2ER, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44-141-2114599; fax: +44-141-5532558
    • ,
  • E.Ann Brown

      Affiliations

    • Department of Pathological Biochemistry, 4th Floor Queen Elizabeth Building, Royal Infirmary University/NHS Trust, Glasgow G31 2ER, UK
    • ,
  • Gillian Docherty

      Affiliations

    • Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK
    • ,
  • Ian Ford

      Affiliations

    • Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK
    • ,
  • for the West of Scotland Coronary Prevention Study Group

      Affiliations

Received 2 March 1999 ,Revised 12 April 1999 ,Accepted 21 June 1999.

References 

  1. Albers JJ, Adolphson JL, Hazzard WR. Radio-immunoassay of human plasma Lp(a) lipoprotein. J. Lipid Res. 1977;18:331
  2. Sandholzer C, Saha N, Kark JD, Rees A, Jaross W, Dieplinger H, et al.  Apo(a) isoforms predict risk for coronary heart disease. Arterioscler. Thromb. 1992;12:1214
  3. Rhoads GG, Dahlen GH, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. J. Am. Med. Assoc. 1986;256:2540
  4. Bostom AG, Cupples LA, Jenner JL, et al.  Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. J. Am. Med. Assoc. 1996;276:544
  5. Armstrong VW, Cremer P, Eberle E, et al.  The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: Dependence on serum LDL levels. Atherosclerosis. 1986;62:249
  6. Dahlén GH. Lipoprotein(a), atherosclerosis and thrombosis. Prog. Lipid Res. 1991;30:189
  7. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: A prospective case-control study in a general population sample of middle-aged men. Br. Med. J. 1990;301:1248
  8. Jauhiainen M, Koskinen P, Ehnholm C, Frick MH, Mänttäri M, Manninen V, et al. Lipoprotein(a) and coronary heart disease risk: A nested case-control study of the Helsinki Heart Study participants. Atherosclerosis. 1991;89:59
  9. Nieminen MS, Mattila KJ, Aalto-Setälä K, Kuusi T, Kontula K, Kauppinen-Mäkelin R, et al.  Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease. Arterioscler. Thromb. 1992;12:58
  10. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction. J. Am. Med. Assoc. 1993;270:2195
  11. Gaw A. Lipoprotein(a) and risk of myocardial infarction (Letter). J. Am. Med. Assoc. 1994;271:1077
  12. Schaefer EJ, Lamon-Fava S, Jenner JL, Mcnamara JR, Ordovas JM, Davis E, et al.  Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid research clinics coronary primary prevention trial. J. Am. Med. Assoc. 1994;271:999
  13. Cremer P, Nagel D, Labrot B, Mann H, Muche R, Elster H, et al.  Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). Eur. J. Clin. Invest. 1994;24:444
  14. Seman LJ, Jenner JL, McNamara JR, Schaefer EJ. Quantification of lipoprotein(a) in plasma by assaying cholesterol in lectin-bound plasma fraction. Clin. Chem. 1994;94:2351
  15. WOSCOPS Study Group. Screening experience and baseline characteristics in the West of Scotland Study. Am J Cardiol 1995; 76:485.
  16. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N. Eng. J. Med. 1995;333:1301
  17. Labeur C, Michiels G, Bury J, Usher DC, Rosseneu M. Lipoprotein(a) quantified by an enzyme-linked immunosorbent assay with monoclonal antibodies. Clin. Chem. 1989;35:1380–1384
  18. Gaw A, Gourlay CWD, Brown EA, Bell MA. Evaluation of a new automated latex agglutination assay for lipoprotein(a): comparison with a manual ELISA. Clin. Chim. Acta. 1997;261:175
  19. Gaw A, Boerwinkle E, Cohen JC, Hobbs HH. Comparative analysis of the apo(a) gene, apo(a) glycoprotein and plasma concentrations of Lp(a) in three ethnic groups-evidence for no common ‘null’ allele at the apo(a) locus. J. Clin. Invest. 1994;93:2526
  20. Kronenberg F, Lobentanz EM, Konig P, Utermann G, Dieplinger H. Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides. J. Lipid Res. 1994;35:1318

PII: S0021-9150(99)00259-2

Atherosclerosis
Volume 148, Issue 1 , Pages 95-100 , January 2000

Article Tools

* Image Usage & Resolution